Gene · 5893
RAD52: RAD52 DNA repair protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RAD52: RAD52 DNA repair protein. Genes, record 5893. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5893
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P43351 | DNA repair protein RAD52 homolog | 418 | 11 | Ensembl, GeneID, HGNC |
Source UniProt
Patents51
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2025137408 A1 | 2025-06-26 | 124 | P43351 | Espacenet |
| WO 2025101994 A2 | 2025-05-15 | 1571 | P43351 | Espacenet |
| EP 4540413 A1 | 2025-04-23 | 5 | P43351 | Espacenet |
| EP 4464338 A2 | 2024-11-20 | 322 | P43351 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8041 | P43351 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8042 | P43351 | Espacenet |
| US 11976334 B2 | 2024-05-07 | 194 | P43351 | Espacenet |
| US 11834686 B2 | 2023-12-05 | 54 | P43351 | Espacenet |
| JP 2023549339 A | 2023-11-24 | 184 | P43351 | Espacenet |
| KR 1020230106633 A | 2023-07-13 | 124 | P43351 | Espacenet |
1 to 10 of 51
See all 51 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,882
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RAD52 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 37 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 29 | 2025 |
| R01ES007061 | Mechanisms of DNA Double-strand Break End Resection and Repair Pathway Choice | 15 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| R01GM058015 | Recombinational Mechanisms of DNA Repair | 13 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 12 | 2025 |
| R35GM118026 | Mechanisms of Genome Integrity | 12 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 10 | 2025 |
| R01CA232425 | The Role of Human RAD52 Protein in Genome Stability | 10 | 2025 |
| P30CA056036 | Translational Research in Cancer | 9 | 2025 |
1 to 10 of 1,882Source NIH's project files
See all 1,882 nih grantsPapers2,797
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer. | Diagnostics (Basel) | 2026 | 42793752 | PubTator, text mining | PubMed |
| Body Mass Index and Facial Aging: Mendelian Randomization and Exploratory Target Prioritization. | Clin Cosmet Investig Dermatol | 2026 | 42668868 | PubTator, text mining | PubMed |
| Evolutionarily Conserved but Mechanistically Distinct Mitochondrial Responses to Loss of Timeless/Swi1. | Biomolecules | 2026 | 42650843 | PubTator, text mining | PubMed |
| TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated DNA damage repair and IRS2 expression in pancreatic cancer. | Cancer Lett | 2026 | 42431391 | PubTator, text mining | PubMed |
| Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2. | ESMO Open | 2026 | 42105598 | PubTator, text mining | PubMed |
| Oxidative Stress, DNA Damage, DNA Repair Inhibition, and Apoptosis Induced by Lead and Cadmium Combined Exposure in TK6 Cells. | Toxics | 2026 | 42043168 | PubTator, text mining | PubMed |
| Mechanism of single-strand annealing from native mass spectrometry and cryo-EM structures of RAD52 homolog Mgm101. | Nucleic Acids Res | 2026 | 42036134 | PubTator, text mining | PubMed |
| Nucleolar expansion: A biomolecular condensate mortality timer. | Geromedicine | 2026 | 42016362 | PubTator, text mining | PubMed |
| Large-scale analysis of FMR1 CGG repeat length and risk of premature ovarian insufficiency in over 92 000 women. | Hum Reprod | 2026 | 42001465 | PubTator, text mining | PubMed |
| Resolution of R-loops and transcription-replication conflicts by SETX-BRCA1-BARD1 complex. | Nat Struct Mol Biol | 2026 | 41917467 | PubTator, text mining | PubMed |
1 to 10 of 2,797
See all 2,797 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5893
GET https://conductscience.org/api/genes/v1/5893/patents?page=2